Live
- World Bank to support farmers of Kerala to adapt climate impacts
- ISL 2024-25: FC Goa eager to continue momentum against in-form Punjab FC
- Bhool Bhulaiyaa 3: Kartik Aaryan’s Horror-Comedy Crosses Rs 100 Crore in 3 Days
- Microsoft CEO Satya Nadella Takes Rs 46 Crore Cut: Details
- Water released to Ravulacheruvu village in Dharmavaram Constituency
- Bihar minister Renu Devi observes Chhath festival in Bettiah
- TN: Leopard kills dog at home stay in Valparai, locals demand immediate capture
- Japan, South Korea, US condemn North Korea's latest missile launches amid rising tensions
- Waqf Bill: Oppn MPs meet LS Speaker, lodge protest against JPC chairman Jagdambika Pal
- Ashok Kumar Garg takes charge as Gurugram MCG commissioner
IIT Delhi transfers 2 indigenous health technologies to industry
Two indigenous healthcare technologies developed by the Indian Institutes of Technology (IIT) researchers were transferred to industry, the Ministry of Electronics and Information Technology (MeitY) said on Thursday.
New Delhi: Two indigenous healthcare technologies developed by the Indian Institutes of Technology (IIT) researchers were transferred to industry, the Ministry of Electronics and Information Technology (MeitY) said on Thursday.
The technologies aim to detect prostate cancer and infectious pathogens early.
DNA Aptamer for prostate cancer detection was transferred to Swapnil Sinha, HUMMSA Biotech, Kolkata, and photonic chip-based spectrometric biosensor technology for pathogen detection was given to Nitin Zaveri, UNINO Healthcare, Mumbai.
Developed under the MeitY-funded project called Nanoelectronics Network for Research and Applications (NNetRA), the technologies were transferred on July 31, at an event hosted by the Indian Institute of Technology Delhi.
"We envision a future where technology transfer drives innovation, collaboration, and sustainable development. Measures should be taken to ensure successful adoption, implementation, and commercialisation of technology," said S. Krishnan, Secretary, MeitY.
The aptamer, developed by Prashant Mishra and team from IIT Delhi is capable of binding to the specific oncogenes and could be useful as theranostics for prostate cancer.
On the other hand, the spectrometric biosensor was developed by Joby Joseph and the team from IIT Delhi. It will enable quick and accurate detection of pathogens, thereby aiding in preventing infectious diseases.
